OBJECTIVE: To compare endocrine profiles and IVF outcomes after using @entity1176 agonists ( @entity4397 ) to trigger final oocyte maturation in @entity1 with @entity3610 ( @entity3610 ) with other hyper-responders. DESIGN: Retrospective cohort study. SETTING: @entity4207 center. @entity1 (S): Forty @entity1 with @entity3610 and 74 hyper-responders without @entity3610 . INTERVENTION(S): @entity4397 trigger. MAIN OUTCOME MEASURE(S): Number of oocytes. RESULT(S): Serum E2, LH, and P levels on the day of @entity4397 trigger and the day after trigger did not differ significantly between groups. There were no significant differences in total number of oocytes or percent mature oocytes obtained between groups after controlling for age, antral follicle count, and total days of stimulation. The overall rate of no retrieval of oocytes after trigger was low (2.6%). Fertilization, implantation, clinical pregnancy, and live-birth rates were similar in the two groups. No @entity1 developed @entity43 ( @entity43 ). CONCLUSION(S): The similar post- @entity4397 trigger hormone profiles and mature oocyte yield support the routine use of @entity4397 trigger to prevent @entity43 in @entity1 with @entity3610 .

Use of gonadotropin-releasing hormone agonist trigger during in  vitro fertilization is associated with similar endocrine profiles and oocyte measures in @entity1 with and without XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'PATIENT'] @entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian hyperstimulation syndrome', 'OHSS'] @entity3610 :: ('MESH:D011085', 'Disease') :: ['polycystic ovary syndrome', 'PCOS'] @entity4397 :: ('CHEBI:63533', 'Chemical') :: ['GnRHa'] @entity4207 :: ('MESH:D007859', 'Disease') :: ['Academic'] @entity1176 :: ('MESH:D007987', 'Chemical') :: ['GnRH']
@entity3610 :: (MESH:D011085,Disease) :: ['polycystic ovary syndrome']
